secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLIANT THERAPEUTICS, INC. (PLRX)
CIK:        0001746473
Form:       8-K
Filed at:   2024-09-27T23:59:59+00:00
Accession:  0001746473-24-000153
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pliant Therapeutics amends bylaws to align with Delaware law and revise stockholder proposal procedures
--------------------------------------------------------------------------------

- Board approved Third Amended and Restated Bylaws effective September 24, 2024.
- Amendments align bylaws with Delaware law developments and include severability provision.
- Revised procedural and disclosure requirements for stockholder director nominations and other business proposals.
- Changes are ministerial and conforming; no substantive operational or financial impact.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1746473/000174647324000153/0001746473-24-000153-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1746473/000174647324000153/plrx-20240924.htm
  HTML page:      https://secwatch.observer/filing/0001746473-24-000153

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer